Administration & Faculty
Ashim Malhotra, BPharm, PhD
2011 Research Scientist
NYU School of Medicine
New York, New York
2006-2010 Postdoctoral Fellowship
NYU School of Medicine
New York, New York
2008 FPGEE Certification
National Association of the Boards of Pharmacy USA
2006 Doctor of Philosophy
Life Sciences: Biochemistry and Molecular Pharmacology
Saint John’s University
Queens, New York
2003 Master of Science
Saint John’s University
Queens, New York
2000 Bachelor of Pharmacy
Hamdard University School of Pharmacy
New Delhi, India
|First Professional Year (P1)|
|PHRM 568||Pulmonary, Cardiac and Renal Pathophysiology:|
|Pharmaceutical and Medical Immunology, Inflammation, Cardiovascular and Renal Pathophysiology|
|PHRM 569||Pulmonary, Cardiac and Renal Pharmacology|
|PHRM 570||Medicinal Chemistry:|
|Pharmacology of NSAIDs|
|PHRM 581||Pharmaceutical Sciences: Endocrine and Sex Hormones (Block Coordinator):|
|Biochemistry of diabetes, Metabolic Syndrome|
|PHRM 583||Pharmaceutical Sciences: Immunology and Toxicology:|
|Basics of transplant rejection, immunosuppressive pharmacology and therapy|
|Second Professional Year (P2)|
|PHRM 766||Clinical and Serological Immunology (Elective)|
Areas of Research & Specialization
I have two main areas of interest: (1) a pediatric cardiomyopathy called Barth Syndrome and (2) pancreatic cancer. In summary, I employ lipidomics and molecular pharmacology for an elucidation of disease mechanisms.
- Barth Syndrome: In cardiomyopathy research, I investigate the molecular pathology of Barth Syndrome (BTHS). BTHS is a rare but fatal, X-linked dilated cardiomyopathy and skeletal myopathy arising due to mutations in the tafazzin gene, the protein product of which is a mitochondrial enzyme of the same name. My work has demonstrated that tafazzin is a transacylase responsible for remodeling the mitochondrial inner membrane phospholipid cardiolipin (CL). We also showed that mutated tafazzin caused myopathic mitochondrial aberrations. Specifically mutated tafazzin containing mitochondria had alterations in lipid profile and evinced cristae membrane collapse involving degenerate supramolecular protein assembly. There were also discrepancies in protein distribution of complex V (ATP synthase) and tafazzin in the mitochondrial supramolecular complexes and therefore perhaps delinquent cristae membrane packing. That this was relevant in the context of cardiocytes was demonstrated when we showed that tafazzin mutations affected mitochondrial development during cardiocyte differentiation. Further, in lymphoblasts obtained from BTHS patients, delinquent CL remodeling was accompanied with mitochondrial accrual of monolysocardiolpin (MLCL), the monodeacylated form of CL. Importantly, we provided evidence that MLCL accumulation could be reversed employing small molecule regulators of calcium independent phospholipase A2, suggesting that in addition to deficient membrane packaging, MLCL amassment was a crucial intracellular lesion in this syndrome. In my current work at the Pacific University School of Pharmacy, I am interested in the development and validation of putative translational therapeutics for Barth Syndrome (BTHS). I will explore the following two broad areas: (1) the role of acute and chronic inflammation in cardiomyopathy and (2) the regulation of mitochondrial calcium in BTHS. For these, I will employ molecular biology, lipidomics and proteomics tools.
- Pancreatic Cancer: A recent area of research interest is investigation into the development and progression of pancreatic cancer. Although rarer than other forms of cancer, pancreatic carcinoma has a poor prognosis since it is usually discovered late. Of the many types of pancreatic neoplasia, I am interested in understanding the mechanistic development of pancreatic ductal dysplasia. In particular my emphasis is on the identification of natural compounds that cause apoptosis in pancreatic cancer cell lines. At the Pacific University School of Pharmacy, I aim to explore alterations in intracellular signal transduction pathways downstream of treating cells with natural compounds such as Diindolylmethane (DIM), Neem leaf extracts and other pharmacognostic agents. These exploratory studies will serve to provide preliminary data for translational therapeutic discovery.
|2010||National Pancreas Foundation Grant. Title: The role of dendritic cells in the immune progression of pancreatitis to pancreatic cancer. PI: Ashim Malhotra. Award: $50,000; completed 2011.|
|2009||Barth Syndrome Foundation Grant. Title: The distribution of tafazzin and cardiolpin in the mitochondrial supramolecular complexes – implications for Barth Syndrome. PI: Ashim Malhotra. Award: $24,000; completed 2010.|
|2005||Eli Lilly. Title: The effect of the anti-cancer drug mechlorethamine on mitochondrial membrane stability. PI:Dipak Haldar. Co-PI:Ashim Malhotra; completed 2006.|
|2004||Eli Lilly. Title:Aging process in the mitochondria: effect on membrane structure. PI:Dipak Haldar. Co-PI: Ashim Malhotra; completed 2005|
Khan, F & Malhotra, A. Introduction to Biochemistry. Medicinal Chemistry for Pharmacy Students. Khan, F & Phillips, A (under contract, 2014 publication date). Jones and Bartlett Publishing: Boston, MA.
Malhotra, A & Khan, F. Pharmacology of Immunosuppressive Agents and Miscellaneous Drugs. Medicinal Chemistry for Pharmacy Students. Khan, F & Phillips, A (under contract, 2014 publication date). Jones and Bartlett Publishing: Boston, MA.
Malhotra, A. Cardiology Applications in Nanotechnology: Proof of Principle. Nanotechnology. Soni, S (under contract, 2014 publication date). IGI Global Publishers.
Malhotra, A. Introduction to Pharmacogenomics. Pharmacotherapeutics for Nurse Practitioner Prescribers, 4thed.Woo, TM & Robinson, ML (under contract, 2015 publication date). FA Davis: Philadelphia, PA.
Peer Reviewed Journal Articles
Acehan D, Malhotra A, Xu Y, Ren M, Schlame M.Cardiolipin affects the supramolecular organization of ATP synthase in mitochondria.Biophys J.2011. 100 (9): 2184-92.
Xu Y, Zhang S, Malhotra A, Edelman-Novemsky I, Ma J, Kruppa A, Cernicica C, Blais S, Neubert TA, Ren M, Schlame M.Characterization of tafazzin splice variants from humans and fruit flies.J Biol Chem.2009. 284 (42): 29230-9.
Malhotra A, Edelman-Novemsky I, Xu Y, Ma J, Schlame M, Ren M. Genetic supressors of Barth Syndrome as potential targets for therapeutic intervention. 2010.Mitochondrion. 10 (2): 207-208.
Malhotra A, Xu Y, Ren M, Schlame M.Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species.Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids.2009.1791 (4): 314-20.
Malhotra A, Edelman-Novemsky I, Xu Y, Plesken H, Ma J, Schlame M, Ren M.Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome.Proc Natl Acad Sci U S A.2009. 106 (7): 2337-41.
Acehan D, Khuchua Z, Houtkooper RH, Malhotra A, Kaufman J, Vaz FM, Ren M, Rockman HA, Stokes DL, Schlame M.Distinct effects of tafazzin deletion in differentiated and undifferentiated mitochondria.Mitochondrion.2009. 9 (2): 86-95.
Xu Y, Malhotra A, Ren M and Schlame M.The enzymatic function of tafazzin.J Biol Chem.2006. 281 (51): 39217-24.
Bedrosian AS, Nguyen AH, Hackman M, Connolly MK, Malhotra A, Ibrahim J, Cieza-Rubio NE, Henning JR, Barilla R, Rehman A, Pachter HL, Medina-Zea MV, Cohen SM, Frey AB, Acehan D, Miller G.Dendritic cells promote pancreatic viability in mice with acute pancreatitis.Gastroenterology.2011. 141 (5): 1915-26.
Connolly M, Ayo D, Malhotra A, Hackman M, Ibrahim J, Bedrosian AS, Cieza-Rubio NE, Henning JR, Pachter HL, Frey AB, Miller G.Dendritic cell depletion exacerbates acetaminophen hepatotoxicity.Hepatology.2011.54 (3): 959-68.
Connolly MK, Bedrosian AS, Malhotra A, Henning JR, Ibrahim J, Vera V, Cieza-Rubio NE, Hassan BU, Pachter HL, Cohen S, Frey AB, Miller G.In hepatic fibrosis, liver sinusoidal endothelial cells acquire enhanced immunogenicity.J Immunol.2010. 185 (4): 2200-8.
Connolloy M, Mallen-St. Clair J, Bedrosian A, Malhotra A, Vera V, Ibrahim J, Pachter L, Bar-Sagi D, Frey A, Miller G.Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor.J Leuk Bio.2009. 87 (4): 713-25.
American Association of the Colleges of Pharmacy (AACP )
American Heart Association (AHA)
New York Academy of Sciences (NYAS)